Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Medivation
Woman Max 99 years
Medivation, Inc
Update Il y a 4 ans
A Multinational Study to Evaluate the Safety and Activity of Enzalutamide in Women Whose Breast Cancer Expresses the Androgen Receptor but Does Not Express Estrogen or Progesterone Receptors, and is Not Amplified for the Epidermal Growth Factor Receptor, HER2 Un ensayo multinacional para evaluar la seguridad y la actividad de Enzalutamida en mujeres con cáncer que expresa el receptor de andrógenos pero no los receptores de estrógenos o progesterona, y no está amplificado por el receptor del factor de crecimiento epidérmico HER2
The primary objective is to determine clinical benefit rate in patients with AR+ triple-negative breast cancer (TNBC). El objetivo principal es determinar la tasa de beneficio clínico en pacient...
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Medivation, Inc
Update Il y a 4 ans
A multinational study to evaluate the safety and effectiveness of enzalutamide in patients whose prostate cancer has not metastasized
To determine the efficacy of enzalutamide compared with placebo as assessed by metastasis free survival (MFS).
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Medivation, Inc
Update Il y a 4 ans
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Dimebon in Patients with Mild-to-Moderate Huntington Disease
Co-Primary Objectives: • To determine the effect of Dimebon as compared to placebo on cognition as measured by the Mini-Mental State Examination (MMSE); and • To determine the effect of Dimebon as com...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Medivation, Inc
Update Il y a 4 ans
2009-011799-31-IE
To assess the following primary and secondary objectives in patients with moderate-to-severe Alzheimer’s disease (AD) and behavioral and psychiatric symptoms: Co-Primary Objectives • To evaluate the e...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2